[go: up one dir, main page]

BRPI0520227A2 - Use of a Nutrient Composition for the Treatment of Sarcoma and Prostate Cancer - Google Patents

Use of a Nutrient Composition for the Treatment of Sarcoma and Prostate Cancer

Info

Publication number
BRPI0520227A2
BRPI0520227A2 BRPI0520227-2A BRPI0520227A BRPI0520227A2 BR PI0520227 A2 BRPI0520227 A2 BR PI0520227A2 BR PI0520227 A BRPI0520227 A BR PI0520227A BR PI0520227 A2 BRPI0520227 A2 BR PI0520227A2
Authority
BR
Brazil
Prior art keywords
treatment
sarcoma
prostate cancer
composition
nutrient composition
Prior art date
Application number
BRPI0520227-2A
Other languages
Portuguese (pt)
Inventor
Matthias Rath
Waheed M Roomi
Vadim Ivanov
Aleksandra Niedzwiecki
Original Assignee
Matthias Rath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matthias Rath filed Critical Matthias Rath
Publication of BRPI0520227A2 publication Critical patent/BRPI0520227A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

USO DE UMA COMPOSIÇçO NUTRIENTE PARA O TRATAMENTO DE SARCOMA E CÂNCER DE PRàSTATA. A presente invenção relaciona-se ao uso de uma composição que compreende um composto de ácido ascórbico, um composto de L-lisina, um composto de L-prolina e um composto de polifenol para a preparação de uma composição farmacêutica para o tratamento de fibrossarcoma ou sarcoma sinovial e câncer de próstata. Além disso, a invenção também se relaciona a um método de tratamento em que a referida composição é administrada a um indivíduo que sofre de fibrossarcoma ou sarcoma sinovial ou câncer de próstata.USE OF A NUTRIENT COMPOSITION FOR THE TREATMENT OF SARCOMA AND PRASTA CANCER. The present invention relates to the use of a composition comprising an ascorbic acid compound, an L-lysine compound, an L-proline compound and a polyphenol compound for the preparation of a pharmaceutical composition for the treatment of fibrosarcoma or synovial sarcoma and prostate cancer. Further, the invention also relates to a method of treatment wherein said composition is administered to an individual suffering from fibrosarcoma or synovial sarcoma or prostate cancer.

BRPI0520227-2A 2005-04-11 2005-04-11 Use of a Nutrient Composition for the Treatment of Sarcoma and Prostate Cancer BRPI0520227A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2005/003766 WO2006108429A1 (en) 2005-04-11 2005-04-11 Nutrient composition for treating sarcoma and prostate cancer

Publications (1)

Publication Number Publication Date
BRPI0520227A2 true BRPI0520227A2 (en) 2009-04-22

Family

ID=35064846

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0520227-2A BRPI0520227A2 (en) 2005-04-11 2005-04-11 Use of a Nutrient Composition for the Treatment of Sarcoma and Prostate Cancer

Country Status (3)

Country Link
EP (1) EP1888061A1 (en)
BR (1) BRPI0520227A2 (en)
WO (1) WO2006108429A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011146635A1 (en) * 2010-05-21 2011-11-24 North Texas Medical Associates Malignant neoplasm treatment protocol

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1465614B1 (en) * 2002-01-11 2008-01-02 Matthias Rath A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer

Also Published As

Publication number Publication date
WO2006108429A1 (en) 2006-10-19
EP1888061A1 (en) 2008-02-20

Similar Documents

Publication Publication Date Title
BRPI0718803B8 (en) compound to inhibit mitotic progression, pharmaceutical composition and in vitro method to inhibit aurora kinase activity in a cell
BRPI0507198A (en) bisarylurea derivatives
BRPI0717907A2 (en) "COMPOUND, PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING A CANCER, INHIBITING OR MODULATING LIPID KINASE ACTIVITY, PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITION, USE OF A COMPOUND AND KIT"
BRPI0510177B8 (en) compound, pharmaceutical composition and use thereof
MX2009004699A (en) Pyridinone compounds.
BRPI0513184A (en) 2-carbamide-4-phenylthiazole derivatives, preparation and application thereof in therapy
BR112012008889A2 (en) spiropiperidine compounds and pharmaceutical use thereof to treat diabetes
BR0315580A (en) Methylene Urea Derivatives
CR20120283A (en) BENZODIAZEPINA BROMODOMINIUM INHIBITOR
CL2007003604A1 (en) Pharmaceutical composition for oral administration comprising the amorphous 17-aminogeldanamycin compound; and its use in the treatment of cancer.
BRPI0516483A (en) preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity
WO2006123113A3 (en) Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
BRPI0611717A2 (en) compound, pharmaceutical composition and use of the compound
BRPI0720551A2 (en) compound or a pharmaceutically acceptable salt thereof, and, use thereof, method for treating cancer, processes for preparing a pharmaceutical composition and a compound or a pharmaceutically acceptable salt thereof
BRPI1014572B8 (en) IMIDAZOPYRAZINES FOR USE AS KINASE INHIBITORS
ECSP088288A (en) DERIVATIVES OF 7- (2-AMINO-1-HIDROXI-ETIL) -4-HYDROXIBENZOTIAZOL-2 (3H) -ONA AS AGONISTS OF ADRENOCEPTORS ß2
BRPI0612845A8 (en) compound, pharmaceutical formulation, methods for treating cancer and for synthesizing a compound of formula
BRPI0919447B8 (en) compounds derived from 1-amino-2-cyclobutylethylboronic acid, pharmaceutical composition and their use to treat cancer
CU20110129A7 (en) VEGF-R2 PIRIDYLOXI-INDOLES INHIBITORS AND USE OF THE SAME FOR THE TREATMENT OF DISEASES
BR112013010310A2 (en) lactam acetylcholine carboxylase inhibitors n1 / n2
NO20085217L (en) Effective pyrimidine derivatives in the treatment of cancer
BRPI0622054B8 (en) compound and pharmaceutical composition
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
ECSP077324A (en) BICYCLIC AMIDAS AS INHIBITORS OF CINASA
BRPI0610850A2 (en) Aryl alkyl acid derivatives, pharmaceutical composition, medicament as well as use of said derivatives

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE AS 3A, 4A, 5A, 6A E 7A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.